Stay updated on MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.

Latest updates to the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page
- Check7 days agoChange DetectedAdded revision v3.4.3 and removed v3.4.2 in the study record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedAdded a new revision entry (v3.4.2) and removed a government funding notice from the version history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check43 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operations was added. The record history shows a new revision tag (v3.4.1) replacing the previous v3.4.0.SummaryDifference0.9%

- Check50 days agoChange DetectedUI updates on the record history page include a new Show glossary option, color-coded changes (green for additions and red for deletions), and release notes indicating Revision: v3.4.0 with the removal of the No FEAR Act Data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check85 days agoChange DetectedRevision: v3.3.3 was added to the Record History, signaling a new version posting. The items listed under deletions—'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'—were removed.SummaryDifference0.2%

- Check107 days agoChange DetectedThe page history shows a new revision label Revision: v3.3.2 added and the prior Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.